Drug Database
Back to search

Poland· PL-100427824

Xefo Rapid

A lornoxicam product containing lornoxicamum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC M01AC05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedXefo RapidATCM01AC05REGISTER NO.PL-100427824PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lornoxicamumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lornoxicam is registered in 5 of 19 countries.

Countries holding a registration under ATC M01AC05 (lornoxicam), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search lornoxicam products by name

Lornoxicam · ATC M01AC05

5 / 19 countries

  • Denmark
  • Finlandprice
  • Japan
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lornoxicam costs, country by country.

Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lornoxicam · price per daily dose (12 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Lornoxicamum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
M01AC05
ATC class
Lornoxicam
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991418700
  • gtin
    05909991418717
  • gtin
    05909991418724
  • gtin
    05909991418731
  • gtin
    05909991418748

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for lornoxicam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lornoxicam against other medicinesHow interaction checks work

Lornoxicam · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lornoxicam in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lornoxicam products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Xefo, Xefo Rapid
  • Bulgaria · Ксефо Рапид, Лорнадo
  • Denmark · Lornoxicam Takeda, Xefo
  • Spain · Lornoxicam Rapid Meiji
  • Greece · Xefo, Xefo Rapid
  • Hungary · Xefo, Xefo Rapid
  • Lithuania · Xefo
  • Latvia · Xefo
  • Romania · Lornoxicam Rompharm, Xefo Rapid
  • Slovakia · Xefo, Xefo Rapid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/16a9a097-e2cf-4870-89f3-540dbc18d829
GET /v1/drugs/16a9a097-e2cf-4870-89f3-540dbc18d829?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "8 mg",
  "packaging": "05909991418700 ¦ Rp ¦ 134677\n10 tabl.\n05909991418717 ¦ Rp ¦ 134678\n20 tabl.\n05909991418724 ¦ Rp ¦ 134679\n30 tabl.\n05909991418731 ¦ Rp ¦ 134680\n50 tabl.\n05909991418748 ¦ Rp ¦ 134681\n100 tabl.",
  "substance": "Lornoxicamum 8 mg",
  "common_name": "Lornoxicamum",
  "pl_product_id": "100427824",
  "pozwolenie_nr": "421/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-11-18"
}
API referenceMCP serverPlans

See everything about lornoxicam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console